Position in ACAD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,926,238
+$1,143,062 QoQ
Shares Held
194,713
+14.6% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. ACAD ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,926,238 | 194,713 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,783,176 | 169,954 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,064,273 | 152,163 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,193,424 | 149,645 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,508,187 | 162,642 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,369,698 | 142,667 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,957,284 | 106,664 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,825,621 | 118,701 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,747,573 | 107,543 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,952,155 | 105,579 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,725,680 | 150,932 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,580,624 | 171,815 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,215,782 | 92,517 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,217,578 | 64,696 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $867,480 | 54,490 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $960,364 | 58,702 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $891,192 | 63,250 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,724,124 | 71,186 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,811,814 | 77,627 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,702,574 | 102,503 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,558,340 | 104,893 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,615,604 | 101,380 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,170,613 | 21,897 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $769,188 | 18,647 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $773,775 | 15,964 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $669,409 | 15,844 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||